Skip to content
Snippets Groups Projects

Rette eksempler svarrapport

Merged Rette eksempler svarrapport
utvikling/standarder:release into master
Merged Gry requested to merge utvikling/standarder:release into master
Compare
and
3 files
+ 63
− 3
Compare changes
  • Side-by-side
  • Inline
Files
3
eksempel/Svarrapport/Svarrapport-v-1-4/Svar_mikrobiologi_dyrkning_v1-4_Ny.xml
+ 23
− 1
@@ -39,7 +39,7 @@
<CollectedSample>
<CollectedDate V="2017-09-13T12:25:57"/>
</CollectedSample>
<TypeCoded S="2.16.578.1.12.4.1.1.8351" V="U" DN="Urin" />
<TypeCoded S="2.16.578.1.12.4.1.1.8351" V="U" DN="Urin"/>
<IdByServProvider>80041141BSC</IdByServProvider>
</AnalysedSubject>
<ResultItem>
@@ -47,18 +47,22 @@
<Heading V="LR" DN="Laboratorieresultat"/>
<TextResultValue>Escherichia coli</TextResultValue>
</TextResult>
<ServType V="N" DN="Ny"/>
<Investigation>
<Id V="NPU06073" S="2.16.578.1.12.4.1.1.7280" DN="U-Bakterier dyrkning"/>
</Investigation>
<IdResultItem>1</IdResultItem>
<StatusInvestigation V="3" DN="Endelig"/>
<RefAnalysedSubject>80041141BSC</RefAnalysedSubject>
<ResultItem>
<TextResult>
<TextResultValue> >100.000 bakterier pr.ml.</TextResultValue>
</TextResult>
<ServType V="N" DN="Ny"/>
<Investigation>
<Id S="2.16.578.1.12.4.1.1.8212" OT="Mengde"/>
</Investigation>
<StatusInvestigation V="3" DN="Endelig"/>
</ResultItem>
</ResultItem>
<ResultItem>
@@ -66,18 +70,22 @@
<Heading V="LR" DN="Laboratorieresultat"/>
<TextResultValue>Klebsiella pneumoniae</TextResultValue>
</TextResult>
<ServType V="N" DN="Ny"/>
<Investigation>
<Id V="NPU06073" S="2.16.578.1.12.4.1.1.7280" DN="U-Bakterier dyrkning"/>
</Investigation>
<IdResultItem>2</IdResultItem>
<StatusInvestigation V="3" DN="Endelig"/>
<RefAnalysedSubject>80041141BSC</RefAnalysedSubject>
<ResultItem>
<TextResult>
<TextResultValue> >1000 CFU/1000 ml.</TextResultValue>
</TextResult>
<ServType V="N" DN="Ny"/>
<Investigation>
<Id S="2.16.578.1.12.4.1.1.8212" OT="Mengde"/>
</Investigation>
<StatusInvestigation V="3" DN="Endelig"/>
</ResultItem>
</ResultItem>
<ResultItem>
@@ -86,10 +94,12 @@
<TextResultValue>64</TextResultValue>
<TextCode S="2.16.578.1.12.4.1.1.8271" V="R" DN="Resistent"/>
</TextResult>
<ServType V="N" DN="Ny"/>
<Investigation>
<Id V="NPU06045" S="2.16.578.1.12.4.1.1.7280" DN="Us-Ampicillin"/>
</Investigation>
<RefIdResultItem>1</RefIdResultItem>
<StatusInvestigation V="3" DN="Endelig"/>
<RefAnalysedSubject>80041141BSC</RefAnalysedSubject>
</ResultItem>
<ResultItem>
@@ -99,10 +109,12 @@
<TextCode S="2.16.578.1.12.4.1.1.8271" V="S" DN="Sensitiv, standarddose"/>
<Unit>mg/L</Unit>
</TextResult>
<ServType V="N" DN="Ny"/>
<Investigation>
<Id V="NPU06044" S="2.16.578.1.12.4.1.1.7280" DN="Us-Mecillinam"/>
</Investigation>
<RefIdResultItem>1</RefIdResultItem>
<StatusInvestigation V="3" DN="Endelig"/>
<RefAnalysedSubject>80041141BSC</RefAnalysedSubject>
</ResultItem>
<ResultItem>
@@ -110,10 +122,12 @@
<Heading V="RSB" DN="Resistensbestemmelse"/>
<TextCode S="2.16.578.1.12.4.1.1.8271" V="S" DN="Sensitiv, standarddose"/>
</TextResult>
<ServType V="N" DN="Ny"/>
<Investigation>
<Id V="NPU06047" S="2.16.578.1.12.4.1.1.7280" DN="Us-Trimetoprim"/>
</Investigation>
<RefIdResultItem>1</RefIdResultItem>
<StatusInvestigation V="3" DN="Endelig"/>
<RefAnalysedSubject>80041141BSC</RefAnalysedSubject>
</ResultItem>
<ResultItem>
@@ -121,10 +135,12 @@
<Heading V="RSB" DN="Resistensbestemmelse"/>
<TextCode S="2.16.578.1.12.4.1.1.8271" V="I" DN="Sensitiv, økt eksponering"/>
</TextResult>
<ServType V="N" DN="Ny"/>
<Investigation>
<Id V="NPU57715" S="2.16.578.1.12.4.1.1.7280" DN="Us-Trimetoprim + Sulfametoksazol"/>
</Investigation>
<RefIdResultItem>1</RefIdResultItem>
<StatusInvestigation V="3" DN="Endelig"/>
<RefAnalysedSubject>80041141BSC</RefAnalysedSubject>
</ResultItem>
<ResultItem>
@@ -132,10 +148,12 @@
<Heading V="RSB" DN="Resistensbestemmelse"/>
<TextCode S="2.16.578.1.12.4.1.1.8271" V="R" DN="Resistent"/>
</TextResult>
<ServType V="N" DN="Ny"/>
<Investigation>
<Id V="NPU06048" S="2.16.578.1.12.4.1.1.7280" DN="Us-Nitrofurantoin"/>
</Investigation>
<RefIdResultItem>1</RefIdResultItem>
<StatusInvestigation V="3" DN="Endelig"/>
<RefAnalysedSubject>80041141BSC</RefAnalysedSubject>
</ResultItem>
<ResultItem>
@@ -143,10 +161,12 @@
<Heading V="RSB" DN="Resistensbestemmelse"/>
<TextCode S="2.16.578.1.12.4.1.1.8271" V="R" DN="Resistent"/>
</TextResult>
<ServType V="N" DN="Ny"/>
<Investigation>
<Id V="NPU06045" S="2.16.578.1.12.4.1.1.7280" DN="Us-Ampicillin"/>
</Investigation>
<RefIdResultItem>2</RefIdResultItem>
<StatusInvestigation V="3" DN="Endelig"/>
<RefAnalysedSubject>80041141BSC</RefAnalysedSubject>
</ResultItem>
<ResultItem>
@@ -154,10 +174,12 @@
<Heading V="RSB" DN="Resistensbestemmelse"/>
<TextCode S="2.16.578.1.12.4.1.1.8271" V="I" DN="Sensitiv, økt eksponering"/>
</TextResult>
<ServType V="N" DN="Ny"/>
<Investigation>
<Id V="NPU57715" S="2.16.578.1.12.4.1.1.7280" DN="Us-Trimetoprim + Sulfametoksazol"/>
</Investigation>
<RefIdResultItem>2</RefIdResultItem>
<StatusInvestigation V="3" DN="Endelig"/>
<RefAnalysedSubject>80041141BSC</RefAnalysedSubject>
</ResultItem>
</Patient>